QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
This work has been published in the journal ‘ACS applied materials and interface’
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Innovative solutions and a deep understanding of the market makes this a unique combination
EPS climbs to Rs 9.25 for the quarter
Subscribe To Our Newsletter & Stay Updated
